Results 11 to 20 of about 23,100 (268)

Sciatic neuropathy developed after injection during curettage

open access: bronzeAğrı - The Journal of The Turkish Society of Algology, 2015
Intramuscular injections are likely the most common cause of sciatic nerve injury in developing countries. Less common causes include piriformis syndrome, primary tumors of the sciatic nerve, metastatic tumors invading or compressing the nerve, endometriosis, vascular malformations, and prolonged immobilization or positioning.
Ayşe, Altıntaş   +5 more
openaire   +3 more sources

An unusual sciatic neuropathy. [PDF]

open access: bronzeJournal of Neurology, Neurosurgery & Psychiatry, 1995
F, Tison, P, Boulan
openaire   +4 more sources

Electrodiagnostic features of sciatic neuropathy: Six-year referral center experience

open access: yesNeurological Sciences and Neurophysiology, 2023
Introduction: Sciatic neuropathy is one of the most important neuropathies of the lower extremity. Although electromyography (EMG) is useful for detecting and localizing neurologic damage, assessing the severity of neuropathy, determining prognoses, and ...
Fatma Gokcem Yildiz   +3 more
doaj   +1 more source

Protective effect of alirocumab, a PCSK9 inhibitor, on the sciatic nerve of rats with diabetic peripheral neuropathy

open access: diamondEndocrine Journal
Dyslipidemia has been considered a risk factor for diabetic peripheral neuropathy. Proprotein convertase subtilisin-like/Kexin 9 inhibitor (PCSK9) inhibitors are a new type of lipid-lowering drug currently in clinical use.
Na Cui   +6 more
doaj   +3 more sources

The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model

open access: yesPharmaceutics, 2022
Little is known regarding the pharmacological properties of extended-release local anesthetics in the setting of diabetic peripheral neuropathy. We investigated and compared the duration of sciatic nerve block following administration of clinically ...
Liljana Markova   +5 more
doaj   +1 more source

Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice. [PDF]

open access: yesPLoS ONE, 2016
We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice.
Lei Wang   +7 more
doaj   +1 more source

Sciatic neuropathy with preserved sensory nerve action potentials, a case series [PDF]

open access: yes, 2020
Background: Sciatic neuropathy is differentiated from lumbosacral radiculopathy based on the finding of abnormal sensory nerve action potentials (SNAPs). Cases of sciatic neuropathy with intact SNAPS have not been well described. Methods: A retrospective
Li, Yuebing   +2 more
core   +2 more sources

Molsidomine ameliorates diabetic peripheral neuropathy complications in Wistar rats

open access: yesAnimal Models and Experimental Medicine, 2021
Diabetic neuropathy is a disorder that affects various regions of the nervous system and there is no specific treatment available for it. This study evaluated the protective effect of molsidomine in diabetic neuropathy in rats.
Pranav Nayak B   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy